Header Logo

Connection

LEO LUZNIK to Methotrexate

Back to Details
This is a "connection" page, showing publications LEO LUZNIK has written about Methotrexate.
LEO LUZNIK
Connection Strength
0.669
Methotrexate
  1. Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies. J Clin Oncol. 2022 02 01; 40(4):356-368.
    View in: PubMed
    Score: 0.669
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.